{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:12:18Z","timestamp":1790403138258,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,4]],"date-time":"2018-07-04T00:00:00Z","timestamp":1530662400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s40478-018-0559-4","type":"journal-article","created":{"date-parts":[[2018,7,4]],"date-time":"2018-07-04T00:37:25Z","timestamp":1530664645000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":138,"title":["The age of onset and evolution of Braak tangle stage and Thal amyloid pathology of Alzheimer\u2019s disease in individuals with Down syndrome"],"prefix":"10.1186","volume":"6","author":[{"given":"Yvonne S.","family":"Davidson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vee P.","family":"Prasher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3960-9863","authenticated-orcid":false,"given":"David M. A.","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,4]]},"reference":[{"key":"559_CR1","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/dmcn.12868","volume":"58","author":"M Alexander","year":"2016","unstructured":"Alexander M, Petri H, Ding Y, Wandel C, Khwaja O, Foskett N (2016) Morbidity and medication in a large population of individuals with Down syndrome compared to the general population. Dev Med Child Neurol 58:246\u2013254","journal-title":"Dev Med Child Neurol"},{"key":"559_CR2","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/nan.12070","volume":"40","author":"N Allen","year":"2014","unstructured":"Allen N, Robinson AC, Snowden S, Davidson YS, Mann DMA (2014) Patterns of cerebral amyloid angiopathy define histopathological phenotypes in Alzheimer\u2019s disease. Neuropathol Appl Neurobiol 40:136\u2013148","journal-title":"Neuropathol Appl Neurobiol"},{"key":"559_CR3","doi-asserted-by":"crossref","unstructured":"Behrouzi R, Liu X, Wu D, Robinson AC, Tanaguchi-Watanabe S, Rollinson S et al (2016) Pathological tau deposition in motor Neurone disease and frontotemporal lobar degeneration associated with TDP-43 proteinopathy. Acta Neuropathol Commun 4:33","DOI":"10.1186\/s40478-016-0301-z"},{"key":"559_CR4","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239\u2013259","journal-title":"Acta Neuropathol"},{"key":"559_CR5","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s007020050096","volume":"105","author":"H Braak","year":"1998","unstructured":"Braak H, Braak E (1998) Argyrophilic grain disease: frequency of occurrence in different age categories and neuropathological diagnostic criteria. J Neural Transm 105:801\u2013819","journal-title":"J Neural Transm"},{"key":"559_CR6","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00401-010-0789-4","volume":"12","author":"H Braak","year":"2011","unstructured":"Braak H, Del Tredici K (2011) The pathological process underlying Alzheimer's disease in individuals under thirty. Acta Neuropathol 12:171\u2013181","journal-title":"Acta Neuropathol"},{"key":"559_CR7","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","volume":"112","author":"H Braak","year":"2006","unstructured":"Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112:389\u2013404","journal-title":"Acta Neuropathol"},{"key":"559_CR8","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1097\/NEN.0b013e318232a379","volume":"70","author":"H Braak","year":"2011","unstructured":"Braak H, Thal DR, Ghebremedhin E, Del Tredici K (2011) Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol 70:960\u2013969","journal-title":"J Neuropathol Exp Neurol"},{"key":"559_CR9","first-page":"457","volume":"73","author":"PC Burger","year":"1973","unstructured":"Burger PC, Vogel FS (1973) The development of the pathological changes of Alzheimer\u2019s disease and senile dementia in patients with Down\u2019s syndrome. Am J Pathol 73:457\u2013476","journal-title":"Am J Pathol"},{"key":"559_CR10","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00401-014-1349-0","volume":"128","author":"JF Crary","year":"2014","unstructured":"Crary JF, Trojanowski JQ, Schneider JA, Abisambra JF, Abner EL, Alafuzoff I et al (2014) Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol 128:755\u2013766","journal-title":"Acta Neuropathol"},{"key":"559_CR11","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s00401-011-0879-y","volume":"122","author":"YS Davidson","year":"2011","unstructured":"Davidson YS, Raby S, Foulds PG, Robinson A, Thompson JC, Sikkink S et al (2011) TDP-43 pathological changes in early onset familial and sporadic Alzheimer's disease, late onset Alzheimer's disease and Down\u2019s syndrome: association with age, hippocampal sclerosis and clinical phenotype. Acta Neuropathol 122:703\u2013713","journal-title":"Acta Neuropathol"},{"key":"559_CR12","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3233\/JAD-160836","volume":"56","author":"E Doran","year":"2017","unstructured":"Doran E, Keator D, Head E, Phelan MJ, Kim R, Totoiu M et al (2017) Down syndrome, partial trisomy 21, and absence of Alzheimer\u2019s disease: the role of APP. J Alzheimers Dis 56:459\u2013470","journal-title":"J Alzheimers Dis"},{"key":"559_CR13","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1212\/WNL.24.2.101","volume":"24","author":"WG Ellis","year":"1974","unstructured":"Ellis WG, McCulloch JR, Corley CL (1974) Presenile dementia in Down\u2019s syndrome. Ultrastructural identity with Alzheimer\u2019s disease. Neurology 24:101\u2013106","journal-title":"Neurology"},{"key":"559_CR14","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-V","volume":"12","author":"J Hardy","year":"1991","unstructured":"Hardy J, Allsop D (1991) Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol Sci 12:383\u2013388","journal-title":"Trends Pharmacol Sci"},{"key":"559_CR15","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s40478-017-0499-4","volume":"5","author":"E Head","year":"2017","unstructured":"Head E, Phelan MJ, Doran E, Kim RC, Poon WW, Schmidt FA et al (2017) Cerebrovascular pathology in Down syndrome and Alzheimer disease. Acta Neuropathol Comm 5:93","journal-title":"Acta Neuropathol Comm"},{"key":"559_CR16","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1001\/archneur.1995.00540280065020","volume":"52","author":"PR Hof","year":"1995","unstructured":"Hof PR, Bouras C, Perl DP, Sparks DL, Mehta N, Morrison JH (1995) Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down\u2019s syndrome. Quantitative regional analysis and comparison with Alzheimer\u2019s disease. Arch Neurol 52:379\u2013391","journal-title":"Arch Neurol"},{"key":"559_CR17","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1126\/science.6474172","volume":"225","author":"BT Hyman","year":"1984","unstructured":"Hyman BT, Van Hoesen GW, Damasio AR, Barnes CL (1984) Alzheimer\u2019s disease: cell-specific pathology isolates the hippocampal formation. Science 225:1168\u20131170","journal-title":"Science"},{"key":"559_CR18","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1001\/archneur.1995.00540280059019","volume":"52","author":"BT Hyman","year":"1995","unstructured":"Hyman BT, West HL, Rebeck GW, Lai F, Mann DM (1995) Neuropathological changes in Down\u2019s syndrome hippocampal formation. Effect of age and apolipoprotein E genotype. Arch Neurol 52:373\u2013378","journal-title":"Arch Neurol"},{"key":"559_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","volume":"8","author":"BT Hyman","year":"2012","unstructured":"Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC et al (2012) National Institute on Aging\u2013Alzheimer\u2019s association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease. Alzheimers Dement 8:1\u201313","journal-title":"Alzheimers Dement"},{"key":"559_CR20","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/ana.410370305","volume":"37","author":"T Iwatsubo","year":"1995","unstructured":"Iwatsubo T, Mann DMA, Odaka A, Suzuki N, Ihara Y (1995) Amyloid \u00df-protein (A\u00df) deposition: A\u00df42(43) precedes A\u00df(40) in Down\u2019s syndrome. Ann Neurol 37:294\u2013299","journal-title":"Ann Neurol"},{"key":"559_CR21","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s007020050095","volume":"105","author":"KA Jellinger","year":"1998","unstructured":"Jellinger KA (1998) Alzheimer-type lesions in Huntington\u2019s disease. J Neural Transm 105:787\u2013799","journal-title":"J Neural Transm"},{"key":"559_CR22","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00401-015-1509-x","volume":"131","author":"GG Kovacs","year":"2016","unstructured":"Kovacs GG, Ferrer I, Grinberg LT, Alafuzoff I, Attems J, Budka H et al (2016) Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy. Acta Neuropathol 131:87\u2013102","journal-title":"Acta Neuropathol"},{"key":"559_CR23","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1006\/nbdi.1996.0003","volume":"3","author":"CA Lemere","year":"1996","unstructured":"Lemere CA, Blusztajn JK, Yamaguchi H, Wisniewski T, Saido TC, Selkoe DJ (1996) Sequence of deposition of heterogeneous amyloid beta-peptides and APOE in Down syndrome: implications for initial events in amyloid plaque formation. Neurobiol Dis 3:16\u201332","journal-title":"Neurobiol Dis"},{"key":"559_CR24","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1006\/exnr.1997.6777","volume":"150","author":"JB Leverenz","year":"1998","unstructured":"Leverenz JB, Raskind MA (1998) Early amyloid deposition in the medial temporal lobe of young Down syndrome patients: a regional quantitative analysis. Exp Neurol 150:296\u2013304","journal-title":"Exp Neurol"},{"key":"559_CR25","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/1531-8249(199903)45:3<353::AID-ANA11>3.0.CO;2-4","volume":"45","author":"CF Lippa","year":"1999","unstructured":"Lippa CF, Schmidt ML, Lee VM, Trojanowski JQ (1999) Antibodies to alpha-synuclein detect Lewy bodies in many Down\u2019s syndrome brains with Alzheimer\u2019s disease. Ann Neurol 45:353\u2013357","journal-title":"Ann Neurol"},{"key":"559_CR26","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1001\/archneurol.2009.277","volume":"66","author":"CF Lippa","year":"2009","unstructured":"Lippa CF, Rosso AL, Stutzbach LD, Neumann M, Lee VM, Trojanowski JQ (2009) Transactive response DNA-binding protein 43 burden in familial Alzheimer disease and Down syndrome. Arch Neurol 66:1483\u20131488","journal-title":"Arch Neurol"},{"key":"559_CR27","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.neurobiolaging.2004.08.005","volume":"26","author":"IT Lott","year":"2005","unstructured":"Lott IT, Head E (2005) Alzheimer disease and Down syndrome: factors in pathogenesis. Neurobiol Aging 26:383\u2013389","journal-title":"Neurobiol Aging"},{"key":"559_CR28","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0047-6374(88)90041-3","volume":"43","author":"DMA Mann","year":"1988","unstructured":"Mann DMA (1988) The pathological association between Down syndrome and Alzheimer disease. Mech Ageing Dev 43:99\u2013136","journal-title":"Mech Ageing Dev"},{"key":"559_CR29","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1056\/NEJM198803243181218","volume":"318","author":"DMA Mann","year":"1988","unstructured":"Mann DMA, Esiri MM (1988) The site of the earliest lesions of Alzheimer\u2019s disease. New Eng J Med 318:789\u2013790","journal-title":"New Eng J Med"},{"key":"559_CR30","first-page":"201","volume":"1","author":"DMA Mann","year":"1992","unstructured":"Mann DMA, Younis N, Jones D, Stoddart RW (1992) The time course of pathological events concerned with plaque formation in Down\u2019s syndrome with particular reference to the involvement of microglial cells. Neurodegeneration 1:201\u2013215","journal-title":"Neurodegeneration"},{"key":"559_CR31","doi-asserted-by":"publisher","unstructured":"Mann DMA, Davidson YS, Robinson AC, Allen N, Hashimoto T, Richardson A et al (2018) Patterns and severity of vascular amyloid in Alzheimer\u2019s disease associated with duplications and missense mutations in APP gene, Down syndrome and sporadic Alzheimer\u2019s disease. Acta Neuropathol. \n                    https:\/\/doi.org\/10.1007\/s00401-018-1866-3","DOI":"10.1007\/s00401-018-1866-3"},{"key":"559_CR32","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/0022-510X(86)90179-6","volume":"76","author":"B Marcyniuk","year":"1986","unstructured":"Marcyniuk B, Mann DM, Yates PO (1986) The topography of cell loss from locus caeruleus in Alzheimer\u2019s disease. J Neurol Sci 76:335\u2013345","journal-title":"J Neurol Sci"},{"key":"559_CR33","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/0022-510X(88)90016-0","volume":"83","author":"B Marcyniuk","year":"1988","unstructured":"Marcyniuk B, Mann DM, Yates PO, Ravindra CR (1988) Topography of nerve cell loss from the locus caeruleus in middle aged persons with Down\u2019s syndrome. J Neurol Sci 83:15\u201324","journal-title":"J Neurol Sci"},{"key":"559_CR34","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1111\/bpa.12424","volume":"20","author":"KE McAleese","year":"2017","unstructured":"McAleese KE, Walker L, Erskine D, Thomas AJ, McKeith IG, Attems J (2017) TDP-43 pathology in Alzheimer\u2019s disease, dementia with Lewy bodies and ageing. Brain Pathol 20:472\u2013479","journal-title":"Brain Pathol"},{"key":"559_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","volume":"123","author":"TJ Montine","year":"2012","unstructured":"Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW et al (2012) National Institute on Aging-Alzheimer\u2019s association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: a practical approach. Acta Neuropathol 123:1\u201311","journal-title":"Acta Neuropathol"},{"key":"559_CR36","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.expneurol.2007.11.019","volume":"210","author":"K Obi","year":"2008","unstructured":"Obi K, Akiyama H, Kondo H, Shimomura Y, Hasegawa M, Iwatsubo T (2008) Relationship of phosphorylated \u03b1-synuclein and tau accumulation to A\u03b2 deposition in the cerebral cortex of dementia with Lewy bodies. Expl Neurol 210:409\u2013420","journal-title":"Expl Neurol"},{"key":"559_CR37","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1212\/WNL.47.1.190","volume":"47","author":"JM Olichney","year":"1996","unstructured":"Olichney JM, Hansen LA, Galasko D, Saitoh T, Hofstetter CR, Katzman R et al (1996) The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer\u2019s disease and Lewy body variant. Neurology 47:190\u2013196","journal-title":"Neurology"},{"key":"559_CR38","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1093\/brain\/92.1.147","volume":"92","author":"MI Olson","year":"1969","unstructured":"Olson MI, Shaw CM (1969) Presenile dementia and Alzheimer\u2019s disease in mongolism. Brain 92:147\u2013156","journal-title":"Brain"},{"key":"559_CR39","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.1523\/JNEUROSCI.4854-06.2007","volume":"27","author":"E Planel","year":"2007","unstructured":"Planel E, Richter KE, Nolan CE, Finley JE, Liu L, Wen Y et al (2007) Anaesthesia leads to tau hyperphosphorylation through inhibition of phosphatase activity by hypothermia. J Neurosci 27:3090\u20133097","journal-title":"J Neurosci"},{"key":"559_CR40","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/ana.410430316","volume":"43","author":"VP Prasher","year":"1998","unstructured":"Prasher VP, Farrer MJ, Kessling AM, Fisher EM, West RJ, Barber PC et al (1998) Molecular mapping of Alzheimer-type dementia in Down\u2019s syndrome. Ann Neurol 43:380\u2013383","journal-title":"Ann Neurol"},{"key":"559_CR41","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1002\/gps.2039","volume":"23","author":"VP Prasher","year":"2008","unstructured":"Prasher VP, Schupf N, Sajith SG, Zigman WB, Rees S, Patel A et al (2008) Significant effect of APOE epsilon 4 genotype on the risk of Alzheimer\u2019s disease and mortality in persons with Down syndrome. Int J Geriatr Psychiatry 23:1134\u20131140","journal-title":"Int J Geriatr Psychiatry"},{"key":"559_CR42","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1212\/WNL.30.6.639","volume":"30","author":"AH Ropper","year":"1980","unstructured":"Ropper AH, Williams RS (1980) Relationship between plaques and tangles and dementia in Down\u2019s syndrome. Neurology 30:639\u2013644","journal-title":"Neurology"},{"key":"559_CR43","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1097\/00001756-199412000-00044","volume":"5","author":"MC Royston","year":"1994","unstructured":"Royston MC, Mann D, Pickering-Brown S, Owen F, Perry R, Raghavan R et al (1994) Apolipoprotein E epsilon 2 allele promotes longevity and protects patients with Down\u2019s syndrome from dementia. Neuroreport 5:2583\u20132585","journal-title":"Neuroreport"},{"key":"559_CR44","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/0140-6736(93)91709-U","volume":"342","author":"AM Saunders","year":"1993","unstructured":"Saunders AM, Schmader K, Breitner JC, Benson MD, Brown WT, Goldfarb L et al (1993) Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer\u2019s disease and in other amyloid-forming diseases. Lancet 342:710\u2013711","journal-title":"Lancet"},{"key":"559_CR45","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s00401-016-1580-y","volume":"132","author":"M Shinohara","year":"2016","unstructured":"Shinohara M, Murray ME, Frank RD, Shinohara M, DeTure M, Yamazaki Y et al (2016) Impact of sex and APOE4 on cerebral amyloid angiopathy in Alzheimer\u2019s disease. Acta Neuropathol 132:225\u2013234","journal-title":"Acta Neuropathol"},{"key":"559_CR46","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","volume":"58","author":"DR Thal","year":"2002","unstructured":"Thal DR, R\u00fcb U, Orantes M, Braak H (2002) Phases of a beta-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791\u20131800","journal-title":"Neurology"},{"key":"559_CR47","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s00401-010-0707-9","volume":"120","author":"DR Thal","year":"2010","unstructured":"Thal DR, Papassotiropoulos A, Saido TC, Griffin WS, Mrak RE, K\u00f6lsch H et al (2010) Capillary cerebral amyloid angiopathy identifies a distinct APOE epsilon4-associated subtype of sporadic Alzheimer\u2019s disease. Acta Neuropathol 120:169\u2013183","journal-title":"Acta Neuropathol"},{"key":"559_CR48","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00401-009-0498-z","volume":"118","author":"RO Weller","year":"2009","unstructured":"Weller RO, Boche D, Nicoll JA (2009) Microvasculature changes and cerebral amyloid angiopathy in Alzheimer\u2019s disease and their potential impact on therapy. Acta Neuropathol 118:87\u2013102","journal-title":"Acta Neuropathol"},{"key":"559_CR49","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/0140-6736(91)92823-K","volume":"337","author":"PR Wenham","year":"1991","unstructured":"Wenham PR, Price WH, Blandell G (1991) Apolipoprotein E genotyping by one-stage PCR. Lancet 337:1158\u20131159","journal-title":"Lancet"},{"key":"559_CR50","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/ana.410170310","volume":"17","author":"KE Wisniewski","year":"1985","unstructured":"Wisniewski KE, Wisniewski HM, Wen GY (1985) Occurrence of neuropathological changes and dementia of Alzheimer\u2019s disease in Down\u2019s syndrome. Ann Neurol 17:278\u2013282","journal-title":"Ann Neurol"},{"key":"559_CR51","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.neulet.2005.08.002","volume":"390","author":"WB Zigman","year":"2005","unstructured":"Zigman WB, Jenkins EC, Tycko B, Schupf N, Silverman W (2005) Mortality is associated with apolipoprotein E \u03b54 in non-demented adults with Down syndrome. Neurosci Lett 390:93\u201397","journal-title":"Neurosci Lett"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-018-0559-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40478-018-0559-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-018-0559-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T19:17:39Z","timestamp":1562181459000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-018-0559-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,4]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["559"],"URL":"https:\/\/doi.org\/10.1186\/s40478-018-0559-4","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,4]]},"assertion":[{"value":"21 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by Manchester Brain Bank Management Committee (REC reference 09\/H0906\/52\u2009+\u20095). Under conditions agreed with the Research Ethics Committee, The Manchester Brain Bank can supply tissue or data to researchers, without requirement for researchers to apply individually to the REC for approval.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and approved the final manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"56"}}